Oxytocin Intervention Mitigates Pathological and Behavioral Impairments in APP/PS1 Mice Subjected to Early Social Isolation

Documenti analoghi

• DNLA Delayed the Appearance of Learning and Memory Impairment of APP/PS1 Mice: Involvement of mTOR/TFEB/v‐ATPase Signaling Pathway
  di: Yajuan Wu, et al.
  Pubblicazione: (2025)
• ApoE4 Upregulates GSK ‐3β to Aggravate Alzheimer‐Like Pathologies and Cognitive Impairment in Type 2 Diabetic Mice
  di: Yuying Wang, et al.
  Pubblicazione: (2025)
• AS1842856 Reduces β‐Amyloid Burden via Inhibiting PLA2G4A ‐Mediated Lysosomal Dysfunction in APP / PS1 Mice
  di: Da‐Long He, et al.
  Pubblicazione: (2026)
• Electroacupuncture Prevents Against AD‐Like Phenotypes in APP/PS1 Mice: Investigation of the Mechanisms From Cerebral Microangiopathy
  di: Chen Yang, et al.
  Pubblicazione: (2025)
• RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice
  di: Mengjiao Ying, et al.
  Pubblicazione: (2026)